These results demonstrated that metformin induce ferroptosis through increase oxidative stress level and down-regulate the Nrf2/HO-1 signaling, expanding the potential clinical application of metformin, and providing potential therapeutic agents for lung cancer patients. The gene discussed is NFE2L2; the disease is lung carcinoma.